ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryHealthcareMedical LaboratoriesEpalingesNovigenix SA
Novigenix SA Logo
Verified· 3 sources

Novigenix SA

Summary

About the company

The core activity of Novigenix is the development and application of precision medicine solutions, particularly in the field of cancer early detection and treatment, using liquid biopsy technologies and artificial intelligence (AI) based analysis platforms, such as the LITOSeek platform. The company focuses on researching and developing innovative approaches to cancer treatment, including the identification of new target molecules for drugs and the development of precision medicine approaches for personalized cancer treatment.

AI-generated
Offering

Products & services

Industry:Medical LaboratoriesMedical Technology Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered3
LITOSeek™ platform
Liquid immuno-transcriptomics platform for blood RNA sequencing, multi-omics analysis, biomarker discovery, therapy response prediction, disease monitoring, and precise patient profiling in oncology.
Biomarker testing services
Biomarker services for biopharma and academic centres: ImmunoPD response markers, predictive biomarkers for response and resistance, mechanism-of-action and safety biomarkers, digital cytometry.
Translational medicine solutions
Translational medicine with LITOSeek™ for precise development of new therapeutics, clinical studies and workflows: response markers, resistance markers, mechanisms, safety biomarkers and digital cytometry.
Press

Media

March 6, 2026Media
Novigenix spins-out AI-Powered Immune Intelligence pionneer
startupticker.ch
April 4, 2025Media
Novigenix obtains EUR 1.8 million EU grant to industrialize AI-powered liquid biopsy
startupticker.ch
October 3, 2024Media
EU funds AI-driven medical projects powered by Swiss startups
startupticker.ch
March 11, 2021Media
New appointments at life sciences startups
startupticker.ch
October 18, 2019Media
Fast progress for Novigenix
startupticker.ch

Knowledge

No knowledge articles yet

Once Novigenix SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Novigenix SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Novigenix SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Novigenix SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Route de la Corniche 3
1066 Epalinges

At a glance

Legal form
Corporation
UID
CHE-496.504.999
Founded
2014 · 12 years
Last commercial register change
July 20, 2026
Employees
21 to 50

Similar companies

CD
Centre d'Imagerie du Nord Vaudois (CINOV) SA
Yverdon-Les-Bains
SN
Swiss Nutrition and Health Foundation (SNHf)
Epalinges
TS
TIBIO SAGL, succursale de Suisse romande
Lausanne
UL
Unilabs, Laboratoire d'analyses médicales SA
Coppet